25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 11, 2009, Pages 1280-1285

  Holmøy, Trygve ^a,b,f   Moen, Stine Marit ^b   Gundersen, Thomas A ^c   Holick, Michael F ^d   Fainardi, Enrico ^e   Castellazzi, Massimiliano ^e   Casetta, Ilaria ^e  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Vitas as   (Norway)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF FERRARA   (Italy)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cerebrospinal fluid; Immunology; Multiple sclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; GADOLINIUM; GADOLINIUM PENTETATE;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; RELAPSE; REMISSION;

EID: 70450195964     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509107008     Document Type: Article

References (15)

1. Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 2009. Epub ahead of print 28 April. DOI 10.1007/s00415-009-5139-x.
2. Berger U., Wilson P., McClelland RA, et al. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab 1988; 67: 607-13.
3. Stumpf WE, Sar M., Clark SA, Deluca HF Brain target sites for 1,25-dihydroxyvitamin D3. Science 1982; 215: 1403-05.
4. Baas D., Prufer K., Ittel ME, et al. Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia 2000; 31: 59-68.
5. Sutherland MK, Somerville MJ, Yoong LK, et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: Correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992; 13: 239-50.
6. Eyles DW, Smith S., Kinobe R., Hewison M., McGrath JJ Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005; 29: 21-30.
7. Brown J., Bianco JI, McGrath JJ, Eyles DW 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003; 343: 139-43.
8. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-7.
9. Schumacher GA, Beebe G., Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of the therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552-68.
10. Balabanova S., Richter HP, Antoniadis G., et al. 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr 1984; 62: 1086-90.
11. Holick ME Vitamin D status: Measurement, interpretation and clinical application. Ann Epidemiol 2008; 2: 73-8.
12. Spach KM, Hayes CE Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005; 175: 4119-26.
13. Cooke NE, David EV Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 1985; 76: 2420-24.
14. Gascon-Barre M., Huet PM Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am J Physiol 1983; 244: E266-E271.
15. Pardridge WM, Sakiyama R., Coty WA Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem 1985; 44: 1138-41.